Table 1.
Baseline characteristics of the study group
| Total population | N = 160 |
|---|---|
| Mean age, y | 63.3 |
| Male sex | 73.8 |
| White race | 60 |
| HTN | 56 |
| Dyslipidemia | 42 |
| DM | 17 |
| CAD | 20 |
| LVEF, mean ± SD | 54.9 ± 9 |
| β‐Blocker | 68 |
| CCB | 44 |
| Dofetilide initial dose | |
| 500 µg BID | 87.5 |
| 250 µg BID | 10 |
| 125 µg BID | 2.5 |
| Chronic warfarin | 63 |
Abbreviations: BID, twice daily; CAD, coronary artery disease; CCB, calcium channel blocker; DM, diabetes mellitus; HTN, hypertension; LVEF, left ventricular ejection fraction; SD, standard deviation.
Data are expressed as percentages unless otherwise noted.